Merilda O Blanco-Guzman1, Xiaowen Wang2, Justin M Vader3, Margaret A Olsen1, Erik R Dubberke1. 1. Division of Infectious Diseases, Washington University School of Medicine, St Louis, Missouri, USA. 2. Division of Medical Education, Washington University School of Medicine, St Louis, Missouri, USA. 3. Division of Cardiology, Washington University School of Medicine, St Louis, Missouri, USA.
Abstract
BACKGROUND: Infection is a major complication during circulatory support with a left ventricular assist device (VAD). Changes in device characteristics and treatment practices in the last decade can affect the epidemiology of infection. The International Society for Heart and Lung Transplantation (ISHLT) has published recommendations on the prevention and management of VAD infections, but data to support these recommendations remain sparse. METHODS: We performed a retrospective review of 455 patients who underwent VAD placement from 2009 to 2015. Infection episodes were defined using ISHLT criteria and were also grouped as endovascular or local. Analysis included descriptive statistics. RESULTS: There were 174 patients (38.6%) with a VAD infection. Infection incidence was 36.9 cases per 100 person-years of VAD support. The driveline was the most common infection site (67.2%). Systemic inflammatory response syndrome (SIRS) criteria were not satisfied in 29.2% of patients with endovascular infections, and computed tomography (CT) examinations were normal in 37.7% of cases. Gram-positive bacteria caused 65.6% of infections in patients with an available culture. Antimicrobial suppression was used in 72.3% of patients who survived treatment. Median survival after infection was 35 months for patients with VAD-related infections versus 14 months for patients with VAD-specific infections. CONCLUSIONS: VAD infections continue to be a major complication after implantation. Clinical criteria alone were not predictive of serious infections, and many patients with confirmed infection had normal CTs. Patients with VAD-specific infections had lower median survival than patients with VAD-related infections.
BACKGROUND: Infection is a major complication during circulatory support with a left ventricular assist device (VAD). Changes in device characteristics and treatment practices in the last decade can affect the epidemiology of infection. The International Society for Heart and Lung Transplantation (ISHLT) has published recommendations on the prevention and management of VAD infections, but data to support these recommendations remain sparse. METHODS: We performed a retrospective review of 455 patients who underwent VAD placement from 2009 to 2015. Infection episodes were defined using ISHLT criteria and were also grouped as endovascular or local. Analysis included descriptive statistics. RESULTS: There were 174 patients (38.6%) with a VAD infection. Infection incidence was 36.9 cases per 100 person-years of VAD support. The driveline was the most common infection site (67.2%). Systemic inflammatory response syndrome (SIRS) criteria were not satisfied in 29.2% of patients with endovascular infections, and computed tomography (CT) examinations were normal in 37.7% of cases. Gram-positive bacteria caused 65.6% of infections in patients with an available culture. Antimicrobial suppression was used in 72.3% of patients who survived treatment. Median survival after infection was 35 months for patients with VAD-related infections versus 14 months for patients with VAD-specific infections. CONCLUSIONS: VAD infections continue to be a major complication after implantation. Clinical criteria alone were not predictive of serious infections, and many patients with confirmed infection had normal CTs. Patients with VAD-specific infections had lower median survival than patients with VAD-related infections.
Authors: E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier Journal: N Engl J Med Date: 2001-11-15 Impact factor: 91.245
Authors: Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Véronique L Roger; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2009-12-17 Impact factor: 29.690
Authors: Margaret M Hannan; Shahid Husain; Frauke Mattner; Lara Danziger-Isakov; Richard J Drew; G Ralph Corey; Stephan Schueler; William L Holman; Leo P Lawler; Steve M Gordon; Niall G Mahon; John M Herre; Kate Gould; Jose G Montoya; Robert F Padera; Robert L Kormos; John V Conte; Martha L Mooney Journal: J Heart Lung Transplant Date: 2011-04 Impact factor: 10.247
Authors: Leora T Yarboro; James D Bergin; Jamie L W Kennedy; Carole C Ballew; Emily M Benton; Gorav Ailawadi; John A Kern Journal: Ann Cardiothorac Surg Date: 2014-11
Authors: Mandeep R Mehra; Daniel J Goldstein; Nir Uriel; Joseph C Cleveland; Melana Yuzefpolskaya; Christopher Salerno; Mary N Walsh; Carmelo A Milano; Chetan B Patel; Gregory A Ewald; Akinobu Itoh; David Dean; Arun Krishnamoorthy; William G Cotts; Antone J Tatooles; Ulrich P Jorde; Brian A Bruckner; Jerry D Estep; Valluvan Jeevanandam; Gabriel Sayer; Douglas Horstmanshof; James W Long; Sanjeev Gulati; Eric R Skipper; John B O'Connell; Gerald Heatley; Poornima Sood; Yoshifumi Naka Journal: N Engl J Med Date: 2018-03-11 Impact factor: 91.245
Authors: William L Holman; Soon J Park; James W Long; Alan Weinberg; Lopa Gupta; Anita R Tierney; Robert M Adamson; John D Watson; Edward P Raines; Gregory S Couper; Francis D Pagani; Nelson A Burton; Leslie W Miller; Yoshifumi Naka Journal: J Heart Lung Transplant Date: 2004-12 Impact factor: 10.247
Authors: Rachel J Gordon; Alan D Weinberg; Francis D Pagani; Mark S Slaughter; Pat S Pappas; Yoshifumi Naka; Daniel J Goldstein; Walter P Dembitsky; Julie C Giacalone; Jennifer Ferrante; Deborah D Ascheim; Alan J Moskowitz; Eric A Rose; Annetine C Gelijns; Franklin D Lowy Journal: Circulation Date: 2013-01-11 Impact factor: 29.690
Authors: Andreas Zierer; Spencer J Melby; Rochus K Voeller; Tracey J Guthrie; Gregory A Ewald; Kim Shelton; Michael K Pasque; Marc R Moon; Ralph J Damiano; Nader Moazami Journal: Ann Thorac Surg Date: 2007-08 Impact factor: 4.330
Authors: James K Kirklin; David C Naftel; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Susan L Myers; Marissa A Miller; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2015-10-08 Impact factor: 10.247